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SUMMARY
An overactive renin angiotensin system is associated with obesity and the metabolic syndrome.
However, mechanisms behind it are unclear. Cleaving angiotensinogen to angiotensin I by renin is
a rate-limiting step of angiotensin II production, but renin is suggested to have angiotensin-
independent effects. We generated mice lacking renin (Ren1c) using embryonic stem cells from
C57BL/6 mouse, a strain prone to diet-induced obesity. Ren1c-/- mice are lean, insulin sensitive, and
resistant to diet-induced obesity without changes in food intake and physical activity. The lean
phenotype is likely due to a higher metabolic rate, and gastrointestinal loss of dietary fat. Most of
the metabolic changes in Ren1c-/- mice were reversed by angiotensin II administration. These results
support a role for angiotensin II in the pathogenesis of diet-induced obesity and insulin resistance.
INTRODUCTION
The metabolic syndrome is characterized by central obesity, hypertension, dyslipidemia, and
impaired glucose tolerance. It increases the risks of coronary artery disease and type 2 diabetes,
and is increasingly prevalent (Farmer, 2004). Unifying theories of causality point to primary
defects in insulin action. Alternatively, an overactive renin angiotensin system (RAS) has also
been implicated in inducing the metabolic syndrome. Clinical trials have demonstrated that
pharmacological inhibition of the RAS, using an angiotensin converting enzyme (ACE)
inhibitor or a selective angiotensin receptor AT1 blocker (ARB), improves insulin sensitivity
and decreases the incidence of type 2 diabetes (Scheen, 2004). Mice lacking angiotensinogen,
the renin substrate, are lean and resistant to diet-induced obesity- effects proposed to reflect
increased locomotor activity (Massiera et al., 2001).
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Renin catalyzes the rate-limiting step of angiotensin II (Ang II) production, but it has the
potential for Ang II-independent effects (Nguyen, 2006). We have previously described the
generation of mice lacking renin (Ren1c) using embryonic stem cells from C57BL/6 mouse
(Takahashi et al., 2005). [C57BL/6 mice, like humans, have only one renin gene, Ren1c
(Sigmund and Gross, 1991), and are prone to diet-induced obesity (Surwit, 1988).] As expected,
the Ren1c-/- mice have lower blood pressures, and their plasma levels of renin, Ang I, and Ang
II were undetectable (Takahashi et al., 2005). Here, we report that mice lacking renin are lean,
insulin sensitive, and resistant to diet-induced obesity largely due to lack of Ang II, and that
Ang II-independent direct effects of renin on metabolism are minimal.
RESULTS
The Ren1c-/- mice are lean and resistant to diet-induced obesity, but not lipodystrophic
Compared to wildtype (WT) controls the Ren1c-/- mice weighed significantly less, and the
difference increased with age (Figure 1A). The difference in body weight became more
pronounced on a high fat diet (Table S1 in Supplemental Data, Figure 1B). The weights of the
knockouts did not increase with the diet despite their food intake was not lower than that of
WT mice (Figures 1B, 1C, Table S1). The nose-to-rump lengths indicate that the general linear
body growth of the Ren1c-/- mice was not compromised (Table S1). Their total and percentage
body fat masses were nonetheless less than WT, and did not increase by a high fat diet (Figure
1D). The Ren1c-/- mice had less fat mass than WT controls in all adipose tissue depots tested
(Table S1), and they had smaller adipocytes than WT mice (Figure 1E). Unlike lipodystrophic
mice the Ren1c-/-mice had decreased fat in the liver (Table S1, Figure 1E). Thus, mice lacking
renin are lean and resistant to diet-induced obesity, but are not lipodystrophic.
Increased basal metabolism in mice lacking renin
Possible mechanisms accounting for the leanness of the Ren1c-/- mice and their resistance to
diet-induced obesity include: increased activity-related energy expenditure, increased basal
metabolism, and impaired nutrient absorption. To test the differences in energy balance
between the Ren1c-/- and WT mice, we fed 3~5 month-old mice a high fat diet for 2 weeks
and housed individual mice in Oxymax cages for 5 days. The food consumption and activities
of the Ren1c-/- and WT mice were indistinguishable (Figures 2A, 2B). The total and resting
oxygen consumption and heat generation of the Ren1c-/- mice, normalized to lean body mass
(LBM), were significantly higher than WT (Figure 2C, Table S2). Total heat generation of the
Ren1c-/- mice was 107 kcal/kg LBM/day higher than that of WT mice, which corresponds to
1.26 kcal/mouse/day. Consistent with increased heat generation, expressions of uncoupling
proteins (UCPs) in adipose tissues and the skeletal muscle of these Ren1c-/- mice were
significantly higher than those of WT (Table S3). A more than 10% lower respiratory quotient
(RQ) in the Ren1c-/- mice (Figure 2D) suggests that they have increased fat combustion. This
suggestion is further supported by higher plasma β-hydroxybutyrate (338.9 ± 29.5 μM in
Ren1c-/- and 257.4 ± 18.0 μM in WT, p<0.05) and elevated mRNA expression of liver
mitochondrial HMGCoA synthase 2 (215 ± 16 % in Ren1c-/- and 100 ± 19 % in WT, p<0.01).
Although the Ren1c-/- mice had higher heat generation than WT, the core body temperatures
of the Ren1c-/- and WT mice were indistinguishable (38.3 ± 0.2°C in Ren1c-/-, 38.4 ± 0.1 in
WT, n=9 each, p=0.42). We conclude that increased fatty acid oxidation leads to increased
basal metabolism, which contributes to the resistance to diet-induced obesity observed in mice
lacking renin, and that mice can maintain core body temperature without renin.
Possible mechanisms accounting for the increased basal metabolism include increased
sympathetic nerve activity, hyperthyroidism and hyperadiponectinemia (Bays, 2004). The
Ren1c-/- mice have 30 mmHg lower tail-cuff blood pressures than WT mice (Takahashi et al.,
2005). This could stimulate the sympathetic nervous system, but norepinephrine synthesis in
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adipose tissue depots as well as the plasma concentrations of epinephrine and norepinephrine
did not differ (Table S4). Plasma thyroid hormone levels of the Ren1c-/- mice were not higher
than those of WT mice (Table S5). In contrast, plasma adiponectin levels of these 3~5-month-
old Ren1c-/- mice fed a high fat diet for 4 weeks were almost three times higher than those of
WT (58.0 ± 1.9 μg/ml in Ren1c-/- and 21.0 ± 2.0 in WT, n=8 each, p<0.0001). In addition,
adiponectin has been shown to increase the expression of UCPs (Masaki et al., 2003), which
is consistent with our observation. We conclude that hyperadiponectinemia of the Ren1c-/-
mice likely contributes to their increased fatty acid oxidation and metabolic rate.
Dietary fat wasting in mice lacking renin
Although the food intake of the Ren1c-/- and WT mice did not differ (Figure 2A), the amount
of lipid in the feces, as estimated by the acid steatocrit was more than 2 times higher in the
Ren1c-/- mice (Figure 2E). The dietary fat absorption was 70 mg/mouse/day lower in the
Ren1c-/- mice (Figure 2F), which corresponds to a caloric deficit of 0.63 kcal/mouse/day.
Dietary lipids are predominantry triacylglycerol, which forms micelles together with bile salts,
gets hydrolized by lipases before being absorbed in the small intestine. Bile acid contents in
the liver and intestine were indistinguishable between the two genotypes (Table S6). In
contrast, the expression levels of pancreatic lipase and colipase of the Ren1c-/- mice were both
less than 20% of WT (Figures 2G and 2H). Because one pancreatic lipase molecule requires
one colipase molecule to be active (Chaillan et al., 1989), less than 20% expression of both of
them most likely leads to substantially less lipase activity than WT. In addition, because Ang
II stimulates pancreatic lipase secretion (Tsang et al., 2004), the absence of Ang II in the
Ren1c-/- mice is expected to decrease pancreatic lipase secretion. Further studies are required
to test whether the decrease in pancreatic lipase and colipase that occurs in the Ren1c-/- mice
is the primary cause of steatorrhea.
Decreased Dgat1 expression in the adipose tissue of the Ren1c-/- mice
Ang II stimulates the proliferation and differentiation of preadipocytes in vitro by increasing
expressions of adipogenic genes including transcription factors (Crandall, 1999; Kim et al.,
2001; Saint-Marc et al., 2001). However, their expressions in the Ren1c-/- mice did not differ
from WT (Table S7). Nevertheless, because the adipocytes of the Ren1c-/- mice are small, it
is possible that their ability to synthesize fat is impaired. In support of this possibility we found
that the expression in the white adipose tissue of the Ren1c-/- mice of diacylglycerol
acyltransferase 1 (Dgat1) mRNA, the enzyme catalyzing the last step of triacylglycerol
synthesis, was about half of WT (Figure 2I). The decreased Dgat1 expression was not
compensated by Dgat2 (Table S7). Because Dgat1 heterozygous knockout mice have 40%
body fat of WT controls, and because transplantation of white adipose tissue from the
Dgat1-/- mice to WT mice decreases adiposity (Chen et al., 2003), we conclude that a decrease
in Dgat1 expression in the adipose tissue contributes significantly to the lean phenotype of the
Ren1c-/- mice.
Ren1c-/- mice are insulin sensitive
Consistent with the previous findings that the decrease in Dgat1 is associated with an increase
in adiponectin, and that adiponectin improves insulin sensitivity (Chen et al., 2003; Chen et
al., 2002; Smith et al., 2000), the Ren1c-/- mice had increased plasma adiponectin, decreased
plasma fasting glucose and insulin compared to WT mice especially on a high fat diet (Table
S8). They also required less insulin to maintain similar levels of plasma glucose compared to
WT mice assessed by glucose tolerance test (Figure 3). Because the animals for glucose
tolerance test were 4 months old and on normal chow, they had similar fasting blood glucose
levels, and did not have a large difference in body weight, suggesting that the absence of renin
(and Ang II) increases insulin sensitivity rather than WT mice developing insulin resistance
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secondary to obesity. Together these observations lead to the conclusion that increased plasma
adiponectin in the Ren1c-/- mice probably contributes to their improved insulin sensitivity.
The metabolic phenotype of mice lacking renin is largely explained by lack of Ang II
To determine whether the metabolic phenotype of the Ren1c-/- mice is due to lack of Ang II
caused by the absence of renin or due to Ang II-independent direct effects of renin, we infused
the Ren1c-/- mice with low dose Ang II (1.5 μg/day) and maintained them on a high fat diet
for 4 weeks. Ang II increased body weight, body fat and plasma insulin, and decreased steatocrit
and plasma adiponectin of the Ren1c-/- mice to similar levels of WT without affecting blood
pressure, food intake, blood glucose, and plasma creatinine (Figure 4). Ang II-treated
Ren1c-/- mice also had hydronephrosis similar to untreated knockouts (data not shown).
Next, to test whether the low blood pressure of renin knockout mice could explain the altered
metabolic phenotype, we administered WT mice a high fat diet with an angiotensin receptor
blocker losartan, a Ca channel blocker amlodipine, or a diuretic furosemide for two weeks to
decrease blood pressure to levels similar to those of the Ren1c-/- mice (Figure S1A). The
losartan group showed less of an increase in body weight on a high fat diet, less body fat gain,
lower plasma glucose, and higher plasma adiponectin without changing the food intake and
plasma insulin, indicating losartan makes the animals resistant to diet-induced obesity and
insulin sensitive (Figure S1). Amlodipine and furosemide groups showed similar food intake,
body fat, steatocrit, and insulin sensitivity compared to untreated WT mice on a high fat diet
(Figure S1).
We conclude from these results that the absence of Ang II is sufficient to explain the metabolic
phenotype of the Ren1c-/- mice, that Ang II-independent direct effects of renin are minimal,
and that decreased blood pressure and abnormal kidney function do not contribute to their
metabolic phenotype.
DISCUSSION
To establish the role of renin on the metabolic phenotype in vivo, we have generated mice
lacking renin (Ren1c) using embryonic stem cells from C57BL/6 mouse, a strain prone to diet-
induced obesity. The Ren1c-/- mice are lean, insulin sensitive, and resistant to diet-induced
obesity without changes in food intake and physical activity. The Ren1c-/- mice lose dietary
fat in the feces, which is likely due to decreased expressions of pancreatic lipase and colipase.
They also have high metabolic rate, and increased fatty acid oxidation, which is associated
with decreased expression of Dgat1, and increased adiponectin. Because the adiposity, insulin
sensitivity, and expression levels of Dgat1 of the Ren1c-/- mice are similar to those of the
heterozygous Dgat1+/- mice (Chen et al., 2003), the decreased Dgat1 expression likely
explains the metabolic phenotype of the Ren1c-/- mice. Increased adiponectin is likely at least
partly responsible for high energy expenditure and improved insulin sensitivity of the
Ren1c-/- mice. However, factors other than adiponectin could be also involved in high energy
expenditure and improved insulin sensitivity of the Ren1c-/- mice.
Renin catalyzes the rate-limiting step of Ang II production, but it has the potential for Ang II-
independent effects (Nguyen, 2006). Mice lacking angiotensinogen (Agt), the renin substrate,
are also lean, and resistant to diet-induced obesity (Massiera et al., 2001). However, different
from the Ren1c-/- mice the Agt-/- mice have higher physical activity and similar metabolic rate
compared to WT, and they did not show dietary lipid wasting (Massiera et al., 2001). Because
the Agt-/- mice have very high levels of renin (Tanimoto et al., 1994), Ang II-independent
direct effects of renin could be responsible for the difference in the phenotype between mice
lacking renin and mice lacking angiotensinogen. However, Ang II reverses the metabolic
phenotype of the Ren1c-/-mice without affecting blood pressure, plasma creatinine and
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hydronephrosis. In addition, losartan treated wild type mice fed a high fat diet show
qualitatively similar phenotype as the Ren1c-/- mice, whereas amlodipine and furosemide that
decreased blood pressure of WT mice similar to the levels of the Ren1c-/- mice did not replicate
the metabolic phenotype of the knockout mice. These results indicate that lack of Ang II is
sufficient to explain the metabolic phenotype of mice lacking renin, and Ang II-independent
direct metabolic effects of renin are minimal. Moreover, the developmental defect of their
kidney and low blood pressure per se do not affect the metabolic phenotype of the Ren1c-/-
mice.
Because much of the metabolic phenotype of the Ren1c-/- mice is replicated by losartan, it is
expected that the metabolic phenotype of the Ren1c-/- mice is similar to that of the mice lacking
type 1a Ang II receptor (Agtr1a-/-). Indeed the Agtr1a-/- mice are also lean, resistant to diet-
induced obesity, and show high metabolic rate (Kouyama et al., 2005). Interestingly,
heterozygous Agtr1a+/- mice are also resistant to diet-induce obesity, whereas heterozygous
Ren1c+/- mice are indistinguishable from WT in every parameter measured (data not shown).
This is probably because the plasma and kidney renin levels of the heterozygous Ren1c+/- mice
are indistinguishable from those of WT due to the tight feedback regulation of renin (Takahashi
et al., 2005), whereas the Agtr1a+/- mice express 50% WT level of its gene product (Ito et al.,
1995). However, this does not exclude the possibility that mild increase in the expression of
renin, which we expect in human population, causes obesity and insulin resistance, which is
currently under investigation using our renin overexpressing mice.
Apparent absence of dietary fat wasting in the Agt-/- mice could be because the Soxhlet
extraction method using petroleum benzene they used (Massiera et al., 2001) was not sensitive
enough compared to our acid steatocrit method in quantifying fecal lipid, and was not able to
detect the increase in fecal fat of the Agt-/- mice. Another possibility that could explain the
difference is the difference in genetic backgrounds. Our Ren1c-/- mice were generated using
C57BL/6 embryonic stem cells and maintained on the same strain (coisogenic), whereas the
Agt-/- mice were generated using F1 embryonic stem cells between C57BL/6 and CBA, and
backcrossed to ICR stain of mice (Tanimoto et al., 1994). The difference in the genetic
background possibly introduces differences in gene expressions that modify and obscure the
phenotype. The difference in the genetic background also likely explains why the Agt-/- mice
have higher physical activity and similar metabolic rate compared to WT mice.
Our study demonstrates that mice lacking renin are lean, resistant to diet-induced obesity, and
more insulin sensitive. This metabolically favorable state results partly from increased
metabolic rate, and partly from gastrointestinal loss of dietary fat, but not from increased
physical activity or decreased food intake. Lack of Ang II is sufficient to explain the metabolic
phenotype of mice lacking renin, and Ang II-independent direct effects of renin on metabolism
are minimal. Our finding is particularly relevant since it suggests that renin inhibitors recently
approved or under development for the treatment of hypertension likely have favorable effects




The generation of the Ren1c-/- has previously been described (Takahashi et al., 2005). Mice
were housed in standard cages, on a 12 hr light/dark cycle, and allowed free access to regular
chow and water, and handled in accordance with the NIH guidelines for the use and care of
experimental animals, as approved by the IACUC of UNC-CH. In some experiments, a high
fat diet (TD.88137, Harlan Tekald) was used. Fat content of the regular chow is 17% of calories
and that of the high fat diet is 42% of calories.
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A Lunar PIXImus dual-energy X-ray absorptiometry (DEXA) scanner (Lunar PIXImus Inc.)
was used to estimate the amount of body fat and lean body mass (Brommage, 2003; Nagy and
Clair, 2000).
MRI
In some experiments, body composition of mice was evaluated using EchoMRI-100 (Echo
Medical Systems) according to manufacturer’s instruction.
Metabolic studies
Mice were placed in chamber individually of an Oxymax system (Columbus Instruments) for
96 hrs, and readings were taken 24 hrs after acclimation. Measures of food and water intake,
O2 consumption, CO2 production, respiratory quotient (RQ), and activity were obtained. Data
were collected and analyzed with the Oxymax Windows V2.3 software. Measurement and
settle times were set at 60 and 120 seconds, respectively.
Acid steatocrit
Acid steatocrit was measured as previously described with minor modification (Tran et al.,
1994). In short, 0.05 g of powdered specimen was mixed in 200 μl of 1N perchloric acid. One
drop of 0.5% oil red O was added and mixed. The specimens were placed in nonheparinized
capillary tubes, and spun. Steatocrit was calculated as the 100 × length of fatty layer÷(length
of solid layer + length of fatty layer).
β-hydroxybutyrate, insulin, leptin, adiponectin, T3, T4, and glucose tolerance test
Mice were fasted 4 hrs before blood was drawn. Plasma β-hydroxybutyrate was determined
using a reagent kit (Wako or Sigma-Aldrich). Plasma levels of insulin, leptin and adiponectin
were determined by ELISA kits (Crystal Chem Inc. for insulin and leptin, B-Bridge
International Inc. for adiponectin). T3 and T4 were determined using Coat-A-COUNT
(Diagnostic Products Corporation). Glucose tolerance test was carried out as previously
described (Tsai et al., 2004)
Bile acids
Bile acids were extracted from livers and intestines as previously described (Dawson et al.,
2003; Locket and Gallaher, 1989) and measured using a kit (Wako).
Catecholamine
Norepinephrine and epinephrine in the plasma, hearts and adipose tissues were measured using
HPLC as previously described (Bowers et al., 2004). Norepinephrine turnover, a measure of
its synthesis in the tissue is calculated as previously described (Brodie et al., 1966).
Ang II, losartan, amlodipine, furosemide experiments in vivo
Pellets releasing 1.5 μg/day Ang II or placebo pellets (Innovative Research of America) were
subcutaneously implanted in 6-week-old male Ren1c-/- mice, and the animals were maintained
on a high fat diet. After 4 weeks blood pressure, body composition, food intake, steatocrit, and
plasma glucose, insulin, adiponectin, and creatinine were measured. In another set of
experiment 3-month-old male C57BL/6 WT mice were fed a high fat diet with or without 0.45
g/l losartan (Merck & Co., Inc.) in drinking water containing 5% sucrose, amlodipine 60 mg/
kg food, or furosemide 0.1 g/l in drinking water. After 2 weeks blood pressure, food intakes,
steatocrit, body composition and plasma glucose, insulin and adiponectin were measured.
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mRNA expression was quantified with the ABI Prism 7700 Sequence Detection System
(Applied Biosystems) as described previously (Takahashi et al., 2005). Primers and probes are
listed in Table S9.
Statistical analyses
All values are expressed as mean ± SEM. Data were analyzed by Student’s t test or analysis
of variance (ANOVA). A multiple comparison Tukey-Klamer post-hoc test was performed to
evaluate differences between groups with JMP software version 6 (SAS Institute Inc.).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Ren1c-/- mice are lean and resistant to diet-induced obesity, and store less triacylglycerol
in adipocytes and liver
(A) Growth curves of animals on regular chow (RC). WT: wild type. Error bars represent ±
SEM in all panels of this figure. (B) Changes in the body weight and (C) food intake of male
WT or Ren1c-/- mice induced by 2 month feeding of RC or a high fat diet (HF) starting at 3
months of age. All data are from n=6~9 each group. (D) Body composition and (E) histology
of adipose tissues and livers from mice fed a high fat diet for 8 months starting at 2 months
old. n≥6. *p<0.0001 compared to WT. IWAT: inguinal white adipose tissue; GWAT: gonadal
WAT; RWAT: retroperitoneal WAT; BAT: interscapular brown adipose tissue. Haematoxylin-
eosin staining.
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Figure 2. Ren1c-/- mice generate more heat, excrete more fat in feces, and express less pancreatic
lipase, colipase, and adipose tissue Dgat1
(A) food intake, (B) activity, (C) heat generation, (D) respiratory quotient, (E) fecal acid
steatocrit, and (F) dietary fat absorption of 3~5 month-old males fed a high fat diet for two
weeks. All data are from n=9 each group. Error bars represent ± SEM in all panels of this figure.
mRNA expression of (G) pancreatic lipase, (H) pancreatic colipase, and (I) Dgat1 in GWAT
of 3-month-old males fed regular chow. Closed bars: WT. Open bars: Ren1c-/-. All data are
from n=6~9 each group. *p<0.05, **p<0.005 compared to WT.
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Figure 3. Ren1c-/- mice have improved insulin sensitivity
Plasma glucose (A) and insulin (B) levels during glucose tolerance test. Mice were 4-month-
old males on regular chow. All data are from n=6 each group. *p<0.05, **p<0.001 compared
to WT. Error bars represent ± SEM in both panels of this figure.
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Figure 4. Low dose Ang II abrogates the metabolic phenotype of Ren1c-/- mice
(A) blood pressure, (B) food intake, (C) body weight, (D) body fat (% body weight), (E) fecal
acid steatocrit, (F) plasma glucose, (G) plasma insulin, (H) plasma adiponectin, (I) plasma
creatinine of Ren1c-/- mice implanted with placebo pellets, Ren1c-/- mice implanted with
pellets that release Ang II (1.5 μg/day), and WT control mice implanted with placebo pellets.
All mice were maintained on a high fat diet started at pellet implantation, and the data were
obtained 4 weeks after the treatment. n≥5 each. Error bars represent ± SEM in all panels of
this figure.
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